| March 14, 2013 | ISSUE NUMBER 291 VOL 10 |
Economy
Sequestration: How Big a Hit for FDA, Research, Pharma?
The greatly feared federal budget sequestration mandate went into effect March 1. Federal agencies, including FDA, launched initiatives to comply with the mandated 5% across-the-board cut in spending to minimize the impact on basic operations. The Centers for Disease Control and Prevention (CDC) predicted difficulties tracking and identifying outbreaks in infectious disease, and National Institutes of Health said its loss of $1.6 billion in funding would translate into 2000 fewer research grants, diminishing prospects for new treatments for cancer and other serious diseases ...Read more
Cegedim Relationship Management
Now You Can Enjoy the Sunshine, Not Fear It!
Are you ready for the Sunshine Act transparency reporting requirements? You can be today with AggregateSpend360™–the most widely used aggregate spend reporting solution since 2006. AggregateSpend360 is an easy to use, cloud–based solution that addresses the regulations with features like prebuilt reporting templates to satisfy the federal disclosure requirements.  Learn more.
Patient Adherence
Changing the DNA of Patient Adherence Programs
Epigenetics is the study of changes in human gene expression, in particular from environmental factors. Pharma is also experiencing epigenetic change. The environment has limited the availability of new blockbuster brands and is changing the DNA of our belief systems ...Read More
Marketing
Drug Promotion Office Hopes to Eliminate Silos in Ad Review
The Office of Prescription Drug Promotion (OPDP) is reorganizing its two primary advertising review divisions — professional and consumer — in an attempt to stay in line with the silo-breaking, multi-channel promotional output pouring in from pharma. The line between physician marketing and consumer marketing has blurred as the facets of a brand campaign – from disease and drug-mechanism education to efficacy, safety and lifestyle claims – dovetail across the traditional physician-patient separation. Ben Comer reports ...Read more
CEO Compensation Data
Complete salary, bonus & market capitalization data in biotech.
 www.bioworld.com
Recruitment
Going Global: The New Pharma Workforce
Finding the right people for the right job might seem an afterthought for Big Pharma companies that have cut their US workforce by more than 250,000 in the past 10 years. But the rush is back on for talent: the challenge is making sense of what skills and capabilities will be needed to improve the productivity of human capital as the industry adjusts to a new, more global competitive climate ...Read more
Accelerate Your Brand’s Growth With Connectivity Into the Community Pharmacy
Live Webcast: Wednesday, March 20th, 12:00-1:00pm ET
Register Free at:  www.pharmexec.com/community
Leadership
Pharm Exec's Emerging Pharma Leaders 2013
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input! Tell us who you think should receive Pharmaceutical Executive's Emerging Pharma Leadership Award. Fill out a nomination today ...Read more
|
|
|
 // Precision Health Economics (Los Angeles, CA) hired Amitabh Chandra, PhD, as Chief Scientific Officer. // Sitrof Technologies (Princeton, NJ) announced the promotion of Thomas Kivlehan to Director, Mobility and Collaboration. // TGaS Advisors (East Norriton, PA), a division of KnowledgePoint360, announced the hiring of five new senior staff members: Paul Crotty, Canadian Operations; Chris Caniz, Digital & Relationship Marketing; Bill Lycett and Ken Sher, Training & Development; and Robert Zegel, Executive Commercial Operations.// IMS Health (Parsippany, NJ) acquired Appature (Seattle, WA), a software-as-a-service company, to further expand its commercial services capabilities for life sciences and healthcare organizations.// A group of suppliers of life science marketing and educational services has joined to form DecisionPoint: The Point of Care Communications Association. The nonprofit trade association will focus on educating life science and pharma companies about the value, benefits and proper use of point–of–care communications available for both patient and provider education.// |
|
|
From Focus Reports Ltd., and
Pharm Exec: learn how to do business in Brazil
Last to enter the financial crisis and first to emerge, Brazil has created a new block of middle-class "pharmerging" consumers. Learn key drivers with rapid growth in this ninth-largest market. Report includes key economic data, interviews, and company directory. Download the PDF now.
|
|
|
|
|
 |
|
|
|
|
 |
|
 |
How optimistic are you about your company achieving revenue growth in 2013?
|
|
|
|
